Assessment of medication discrepancy, medication appropriateness, and cost analysis among patients with pediatric nephrotic syndrome: An ambispective cohort observational study

• Published in: Archives de pédiatrie : organe officiel de la Société française de pédiatrie Vol. 31; no. 2; pp. 106 - 111
• Main Authors: Avvaru, Deepthi, Reddy, M Santhosh, MS, Shinaj Azar, Wali, Shashikala, Patil, Mahantesh V, Bhandari, Ramesh, Ganachari, M S
• Format: Journal Article
• Language: English
• Published: France Elsevier Masson SAS 01.02.2024
• Subjects: Cost analysis; Medication appropriateness; Medication discrepancies; Medication reconciliation; Nephrotic syndrome; Medication discrepancies; Nephrotic syndrome; Medication reconciliation; Cost analysis; Medication appropriateness
• ISSN: 0929-693X; 1769-664X
• DOI: 10.1016/j.arcped.2023.09.015

Nephrotic syndrome (NS) is a commonly encountered chronic kidney disease in pediatric populations, with South Asian children being at high risk and requiring long-term pharmacological management. Thus, identifying medication discrepancies and evaluating the appropriateness of therapy and its economic burden are vital for inpatient management. The aim of the study was to assess medication reconciliation, medication appropriateness, and cost analysis in NS cases. An ambispective cohort observational study was carried out with 150 NS patients where medication discrepancies were identified retrospectively and prospectively using the best possible medication history and following up patients correspondingly. Further, the Medication Appropriateness Index and cost variation analysis were used to assess the prescribed therapy and cost analysis, respectively. Out of 150 patients with NS included, 67.3% were male and the mean age was 7.2 years. In total, 36.7% medication discrepancies were found at baseline and 6% discrepancies at follow-up. The majority of discrepancies were unintentional and due to dosing error both at baseline and follow-up. Further, in only 2% of the patients was there inappropriately prescribed medication, and the majority of patients spent between INR (Indian Rupees) 500 and 1000. Chronic conditions like NS require continuous monitoring by the specialist pediatric clinical pharmacist, who can contribute significantly by minimizing the medication discrepancies, by assessing the appropriateness of therapy, and lessening the economic burden.